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RESEARCH ARTICLE
Identification of benzopyrone as a common structural feature in
compounds with anti-inflammatory activity in a zebrafish
phenotypic screen
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Matthew J. Foulkes2,4, Marco M. Meloni4, Xingang Wang5, Christopher Ford6,7, Malcolm Jackson6,7,
Philip W. Ingham8, Heather L. Wilson1,2, Stuart N. Farrow9, Roberto Solari10, Roderick J. Flower11,
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ABSTRACT
Neutrophils are essential for host defence and are recruited to sites
of inflammation in response to tissue injury or infection. For
inflammation to resolve, these cells must be cleared efficiently and
in a controlled manner, either by apoptosis or reverse migration. If the
inflammatory response is not well-regulated, persistent neutrophils
can cause damage to host tissues and contribute to the pathogenesis
of chronic inflammatory diseases, which respond poorly to current
treatments. It is therefore important to develop drug discovery
strategies that can identify new therapeutics specifically targeting
neutrophils, either by promoting their clearance or by preventing their
recruitment. Our recent in vivo chemical genetic screen for
accelerators of inflammation resolution identified a subset of
compounds sharing a common chemical signature, the bicyclic
benzopyrone rings. Here, we further investigate the mechanisms of
action of the most active of this chemical series, isopimpinellin, in our
zebrafish model of neutrophilic inflammation. We found that this
compound targets both the recruitment and resolution phases of the
inflammatory response. Neutrophil migration towards a site of injury is
reduced by isopimpinellin and this occurs as a result of PI3K
inhibition. We also show that isopimpinellin induces neutrophil
apoptosis to drive inflammation resolution in vivo using a new
zebrafish reporter line detecting in vivo neutrophil caspase-3 activity
and allowing quantification of flux through the apoptotic pathway in
real time. Finally, our studies reveal that clinically available
‘cromones’ are structurally related to isopimpinellin and have
previously undescribed pro-resolution activity in vivo. These
findings could have implications for the therapeutic use of
benzopyrones in inflammatory disease.
KEY WORDS: Zebrafish, Inflammation, Neutrophil apoptosis,
Chromone, Benzopyrone
INTRODUCTION
The acute inflammatory response is an essential host defence
mechanism and is initiated by the innate immune system in the event
of tissue injury or infection. It is a highly controlled sequence of
events that involves the coordinated activity of multiple cytokines,
lipid mediators and cell types, and can be broadly split into three
phases: recruitment, peak inflammation and resolution (Serhan
et al., 2007). One of the most important innate immune cells
involved in the inflammatory response is the neutrophil. During the
recruitment phase, these cells are activated in response to
inflammatory stimuli and migrate to inflamed tissue, following
gradients of soluble chemokines such as interleukin-8 (IL-8 or
CXCL8) (Medzhitov, 2008). This chemokine signals via CXCR2
receptors on the neutrophil surface to activate downstream pathways,
including the phosphatidylinositol 3-kinase (PI3K) pathway that is
required for neutrophil chemotaxis (Ferguson et al., 2007; Hirsch
et al., 2000; Yoo et al., 2010). Once at the site of inflammation,
neutrophils eliminate any invading pathogens by phagocytosis,
degranulation and the production of reactive oxygen species and
extracellular traps (Fox et al., 2010). Inflammation must then resolve
in order to restore homeostasis and promote tissue repair. During the
resolution phase, neutrophils are removed either by undergoing
apoptosis and engulfment by macrophages, or by leaving the site of
inflammation by reverse migration (Henry et al., 2013).
If inflammation is not well-regulated, persistent neutrophilic
inflammation can cause host tissue damage and chronic
inflammation, which can contribute to the pathogenesis of
diseases such as chronic obstructive pulmonary disease (COPD),
rheumatoid arthritis and atherosclerosis (Serhan et al., 2007). Many
of these are characterised by unresolved neutrophilic inflammation
and respond poorly to current therapies, making the neutrophil a key
target for drug discovery approaches. Potentially, drugs used to treat
inflammatory disease might act either by preventing the further
recruitment and accumulation of neutrophils at inflammatory sites
(‘anti-inflammatory’) or by promoting neutrophil clearance to drive
inflammation resolution (‘pro-resolution’).Received 31 January 2016; Accepted 4 April 2016
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The zebrafish (Danio rerio) is a powerful model for the study of
vertebrate biology. The development of transgenic lines labelling
innate immune cells has enabled in vivo investigation of the
mechanisms regulating the different phases of the inflammatory
response (Ellett et al., 2011; Hall et al., 2007; Mathias et al., 2006;
Renshaw et al., 2006). With its transparent larvae, small size and
high fecundity, the zebrafish model lends itself particularly well to
drug discovery by high-throughput chemical genetic screening, and
multiple success stories are emerging using this unique whole-
organism approach (Hall et al., 2014; North et al., 2007; Takaki
et al., 2012; Tamplin et al., 2015; Wang et al., 2014).
We recently described a chemical genetic screen for accelerators
of inflammation resolution, in which we found the first compound
that could promote neutrophil reverse migration to drive
inflammation resolution in vivo (Robertson et al., 2014). Here, we
investigate the mechanism of action of the largest described,
structurally distinct subset of active compounds from an in vivo
chemical genetic anti-inflammatory screen. These compounds share
both structural and functional similarity and their activity is two-
fold: neutrophil recruitment is inhibited and inflammation
resolution is accelerated. We also describe a new zebrafish
reporter line for in vivo neutrophil caspase-3 activity, which
allows us to visualise neutrophil apoptosis during inflammation
resolution in real time. Finally, our studies led to the discovery of a
previously undescribed mechanism of action for a group of
clinically available therapeutics, the cromones, which could
impact on their use in inflammatory disease.
RESULTS
Zebrafish inflammation drug screen identifies a chemical
series with structural and functional similarity
We recently established a drug screening assay in a transgenic
zebrafish model of acute inflammation and identified 21 new pro-
resolution compounds (Robertson et al., 2014). Structural similarity
comparisons revealed that a particular chemical group, consisting of
fused benzene and pyran rings with an attached carbonyl group, was
common to a subset of these. Commonly referred to as ‘chromone’
(1,4-benzopyrone), this group or its isomer ‘coumarin’ (1-
benzopyran-2-one) is present in four of the nine most-active pro-
resolution compounds identified in our screen (Fig. 1A). All four of
these significantly accelerated inflammation resolution in our
zebrafish tail-fin injury model and three of them also inhibited
neutrophil recruitment (Robertson et al., 2014). To further
investigate the functionality of benzopyrone derivatives, we tested
a further ten commercially available related compounds and also
synthesised a series of five analogue compounds for testing in our
zebrafish inflammation resolution assay. Larvae were treated with
compounds once inflammation was already established at 6 hours
post-injury (hpi) and their effects on neutrophil number were
assessed at 12 hpi. All of the commercially available compounds
significantly reduced neutrophil numbers at the wound (Fig. S1),
along with three of our newly synthesised analogues (Fig. S2). To
explore the potential significance of this functional group in
accelerating inflammation resolution, we selected the most active of
the benzopyrone subset identified in our screen, isopimpinellin, for
mechanistic investigation.
Isopimpinellin inhibits neutrophil recruitment in vivo
Isopimpinellin is a naturally occurring coumarin found in plants of
the Apiaceae family. It has been studied for its potential anti-
carcinogenic properties (Kleiner et al., 2002; Prince et al., 2006), but
there is currently no published evidence to explain its anti-
inflammatory activity. We initially investigated the effect of
isopimpinellin on the recruitment phase of the inflammatory
response in the tail-fin injury assay, by treating zebrafish larvae
immediately after wounding. At 6 hpi, we found that neutrophil
number at the wound was reduced in isopimpinellin-treated larvae
compared to controls, in a concentration-dependent manner
(Fig. 1B). When individual neutrophils were tracked during the
recruitment phase of inflammation, we detected a decrease in
neutrophil speed (Fig. 1C), displacement (the linear distance each
neutrophil travelled towards the wound) (Fig. 1D) and meandering
index (the displacement divided by the total length of the neutrophil
track) (Fig. 1E). We also found a difference in bearing (the angle of
movement towards the wound) between the two groups, with fewer
neutrophils moving towards the wound in the presence of
isopimpinellin (Fig. 1F). These data suggest that isopimpinellin
alters the migratory behaviour of neutrophils, such that they move
more slowly and with less directionality, resulting in reduced
recruitment towards the chemokine gradient at the wound.
Isopimpinellin inhibits neutrophil recruitment upstream of
phosphatidylinositol 3-kinases
In our previous study, we compared the activity of the positive hits
identified in our screen with a panel of compounds with known
effects on inflammatory signalling pathways, such as inhibitors of
PI3K and mitogen-activated protein kinase (MAPK), using
hierarchical cluster analysis (Robertson et al., 2014). This
indicated that the activity of isopimpinellin in our zebrafish
inflammation assays correlated with a pan-inhibitor of PI3K,
ZSTK474. In vivo evidence suggests that PI3K regulates
neutrophil polarity and that its activation at the leading edge of
cells is required for actin polymerisation during chemotaxis (Yoo
et al., 2010). This is dependent on the tightly controlled spatial and
temporal accumulation of phosphatidylinositol (3,4,5)-triphosphate
(PIP3), protein kinase B (Akt) and actin at the leading edge, a
process that is impaired in neutrophils lacking PI3Kγ (Hannigan
et al., 2002; Ferguson et al., 2007). Based on the correlation between
isopimpinellin and ZSTK474 revealed by cluster analysis, we
predicted that the effect of our hit compound on neutrophil
migration during the recruitment phase of inflammation was a result
of PI3K inhibition and loss of the intracellular polarity required to
direct migration. To investigate this, we used a fluorescent reporter
line, which labels the pleckstrin homology (PH) domain of Akt with
EGFP to permit visualisation of localised PI3K activity in vivo
(Burgon et al., 2014; Wang et al., 2014). In vehicle control-treated
larvae, the EGFP signal accumulated at the leading edge of
neutrophils as they migrated towards the wound shortly after tail-fin
injury (Fig. 2A). In contrast, neutrophils from isopimpinellin-treated
larvae did not migrate as readily to the wound and most of these did
not have a defined leading edge (Fig. 2B), displaying a morphology
characteristic of neutrophils from larvae exposed to the PI3K
inhibitor LY294002 (Fig. 2C). Using a numerical measure of cell
polarity (‘polarity index’) (Wang et al., 2014), we found that
isopimpinellin reduced neutrophil polarity to a level comparable to
LY294002 (Fig. 2D). We also examined the effect of another
compound from our benzopyrone subset, xanthone, finding a
similar reduction in neutrophil polarity (Fig. 2E).
Isopimpinellin induces apoptosis of neutrophils during
inflammation resolution in vivo
We originally identified isopimpinellin as a new pro-resolution
compound in our screen for accelerators of inflammation resolution
(Robertson et al., 2014). On further investigation, we found that
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when zebrafish larvae were exposed to isopimpinellin once
inflammation was already established at 6 hpi, there was a
concentration-dependent reduction in neutrophil numbers at the
wound at 12 hpi (Fig. 3A). Isopimpinellin did not affect total
neutrophil number in whole larvae (Fig. 3B). In our previous study,
we showed that we could pharmacologically drive inflammation
resolution by promoting neutrophil reverse migration (Robertson
et al., 2014). To investigate whether isopimpinellin could also act
Fig. 1. Isopimpinellin inhibits neutrophil migration towards tissue injury. (A) Isopimpinellin shares structural similarity to three other compounds identified in
our previous drug screen for accelerators of inflammation resolution (Robertson et al., 2014). Common benzopyrone structures are highlighted in magenta.
(B) Recruitment assay in mpx:GFP larvae treated with varying doses of isopimpinellin immediately post-injury. Isopimpinellin significantly reduces neutrophil
numbers at the wound at 6 hpi in a dose-dependent manner (one-way ANOVA with Dunnett’s multiple-comparison post-test; *P<0.05, ***P<0.001; n=18,
performed as three independent experiments). Dotted line at y=20.17 indicates mean neutrophil number at wound in DMSO control larvae. (C-F) Neutrophil
tracking assay inmpx:GFP larvae pretreated with DMSO or 25 μM isopimpinellin for 2 h prior to tail fin-injury and time-lapsed from 1 to 3 hpi. Individual neutrophils
were tracked manually to analyse (C) speed, (D) displacement towards the wound and (E) meandering index. All were reduced in isopimpinellin-treated larvae
compared to DMSO controls (unpaired t-test; ***P<0.001; n=26, performed as three independent experiments). Data points represent mean of six tracked
neutrophils per fish. For bearing (F), angles of 0° to 180° indicate migration towards the wound, whereas 180° to 360° indicate migration away from the wound
(one-way ANOVA with Bonferroni’s multiple-comparison post-test to compare selected columns; ***P<0.001; n=30, performed as three independent
experiments).
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via this mechanism, we photoconverted neutrophils specifically at
the wound region at 6 hpi in Tg(mpx:Gal4);Tg(UAS:Kaede)i222
larvae, as described (Elks et al., 2011; Holmes et al., 2012).
However, we found that fewer photoconverted neutrophils migrated
away from the wound over time in isopimpinellin-treated larvae
compared to the vehicle controls (Fig. 3C).
During the course of inflammation resolution in these larvae, we
often observed neutrophils adopting a rounded and condensed
morphology, characteristic of the apoptotic phenotype we have
previously reported (Loynes et al., 2010) (Fig. 3D). To further
investigate neutrophil apoptosis as a pro-resolution mechanism in
zebrafish, we developed a new Tg(mpx:FRET)sh237 reporter line
by targeting a fluorescence resonance energy transfer (FRET)-based
reporter for caspase-3 activity (Tyas et al., 2000) into our
myeloperoxidase bacterial artificial chromosome (BAC) (Renshaw
et al., 2006). This FRET reporter consists of a CFP-YFP fluorophore
pair linked by the caspase-3 cleavage sequence DEVD, such that,
when caspase-3 is activated, the linker peptide is cleaved and the
FRET signal is lost. Neutrophil apoptosis is caspase-3-dependent
(Pongracz et al., 1999) and caspase-3 has been characterised in
zebrafish, sharing 62% identity to human caspase-3 and the same
substrate specificities (Yabu et al., 2001). When imaged during the
resolution phase of inflammation, we detected an increase in the
number of apoptotic events occurring in neutrophils at the site of
injury in isopimpinellin-treated mpx:FRET larvae (Fig. 3E), but no
apoptotic events were ever seen in the head region of the embryo,
suggesting that this is an inflammation-specific response. In
apoptotic cells, we observed loss of the FRET signal, indicative
of caspase-3 activity, shortly after ‘cell rounding’, and the YFP
acceptor fluorescence was lost 5 to 10 minutes later (Fig. 3F). The
pro-apoptotic effect of isopimpinellin was validated using dual
TSA/TUNEL staining, which also revealed an increase in the
percentage of neutrophil apoptosis at the wound (Fig. 3G). We have
previously shown that the pan-caspase inhibitor Z-VAD-FMK
blocks neutrophil apoptosis, whereas pyocyanin and roscovitine can
accelerate it (Loynes et al., 2010). To further illustrate the utility of
this novel transgenic line, we used Z-VAD-FMK to demonstrate a
reduction in the isopimpinellin-induced increase in observable
apoptotic events (Fig. 3H), and pyocyanin and roscovitine to
demonstrate an increase in apoptotic events (Fig. 3I), which were
revealed in real time in vivo for the first time.
Isopimpinellin and related disodiumcromoglycate do not act
as antioxidants
Isopimpinellin is structurally related to khellin, a naturally occurring
benzopyrone also found in plants of the Apiaceae family. Originally
used in ancient Egyptian folk medicine, it was discovered in the
mid-1900s that khellin in its isolated formwas an effective treatment
for bronchial asthma, and this led to the development of a series
of functional benzopyrone analogues, including disodium
cromoglycate and nedocromil (Fig. 4A), collectively termed the
‘cromones’, which are now in clinical use (Edwards and Howell,
Fig. 2. Isopimpinellin and xanthone inhibit polarisation of neutrophils upstreamof PI3K. Assay tomeasure the polarity index of neutrophils in Tg(lyz:PHAkt-
EGFP) larvae pretreated with 25 μM isopimpinellin, 25 μM xanthone, 50 μM LY294002 or DMSO as a vehicle control for 2 h prior to tail-fin injury. Representative
images of individual neutrophils in the region between the wound site and posterior blood island illustrate polarisation and a defined leading edge of a migrating
neutrophil in (A) DMSO control-treated larvae, compared to (B) isopimpinellin- and (C) LY294002-treated larvae, which do not polarise or have a defined
leading edge (scale bars: 11 μm). Arrows indicate direction of wound. Fluorescence (referred to as grey value) was measured in a transection of each neutrophil
(the yellow lines drawn through the cells) to generate intensity profiles shown in the panels on the left and quantify neutrophil polarity index as previously
described (Wang et al., 2014). Both (D) isopimpinellin and (E) xanthone reduced the neutrophil polarity index to a similar level as the known PI3K inhibitor
LY294002 (one-way ANOVA with Dunnett’s multiple-comparison post-test; **P<0.01, ***P<0.001; n=27, performed as three independent experiments).
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2000). These and other structurally related coumarins and
flavonoids have been reported to possess antioxidant activity
(Bubols et al., 2013). To explore this as a potential mechanism of
action for our compounds, we analysed their reducing ability using
the ferric reducing ability of plasma (FRAP) assay (Benzie and
Strain, 1996). Antioxidants are preferentially oxidised over another
substrate, and their oxidation results in the reduction of another
component. Therefore, a good antioxidant will also be a good
reducing agent. Using this method, we found that the known
antioxidant ascorbic acid showed strong reducing ability, at levels
consistent with previous studies (Benzie and Strain, 1996), and
vanillic acid also exhibited substantial reducing ability. However,
neither isopimpinellin nor disodium cromoglycate showed
appreciable reducing ability in this assay, suggesting that these
compounds are unlikely to be acting as antioxidants in our studies
(Fig. 4B,C and Table S1). Furthermore, when we compared the
relative chemical reducing ability of these four compounds with
their effect on the resolution of inflammation in vivo, we found that
there was actually an inverse correlation between biological activity
and chemical reducing ability (Fig. 4D). Our most active pro-
resolution compounds in vivo showed little chemical reducing
ability, whereas neither ascorbic acid nor vanillic acid, known
antioxidants, exhibited a pro-resolution effect in our model
(Fig. S3). To explore this in an in vivo setting, we measured the
Fig. 3. See next page for legend.
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effect of isopimpinellin on hydrogen peroxide (H2O2), an important
reactive oxygen species (ROS) signal known to promote neutrophil
accumulation following tissue injury (Niethammer et al., 2009).
Using a ROS sensor (Rieger and Sagasti, 2011), there was no
reduction in the intensity of the H2O2 gradient at the tail-fin wound
in zebrafish larvae pretreated with isopimpinellin, in contrast to the
potent effect observed in the presence of the NAPDH oxidase
inhibitor diphenyleneiodonium (DPI) (Fig. 4E,F). Taken together,
these data suggest that this subset of compounds do not exhibit their
activity by acting as antioxidants in our zebrafish inflammation
assays.
Isopimpinellin and related cromones do not induce human
neutrophil apoptosis in vitro
The precise anti-inflammatory mechanisms of the cromones are not
fully defined but are likely to be mediated by secretion of the
calcium and phospholipid-binding protein, Annexin A1 (AnxA1)
(Yazid et al., 2009, 2010). AnxA1 is thought to induce neutrophil
apoptosis in a caspase-3-dependent manner and might also function
as an ‘eat me’ signal to promote the phagocytosis of apoptotic
neutrophils by macrophages (Arur et al., 2003; Scannell et al., 2007;
Vago et al., 2012). Having observed a pro-apoptotic effect on
zebrafish neutrophils in vivo, we hypothesised that isopimpinellin
and the related clinical cromones might act similarly on human
neutrophils, and that this might be a previously unidentified pro-
resolution mechanism of this series of compounds. Neutrophils
were freshly isolated from whole blood and incubated with
isopimpinellin, disodium cromoglycate or nedocromil in either
the presence or absence of the neutrophil survival signal
granulocyte-macrophage colony-stimulating factor (GM-CSF).
Unexpectedly, after 8 hours, we found no difference in the
percentage of apoptosis in neutrophils exposed to any of the three
compounds compared to their vehicle control and none of them
were able to override the survival effect of GM-CSF (Fig. 5A-C). It
is known that neutrophil lifespan is prolonged by glucocorticoids
(Heasman et al., 2003; Liles et al., 1995) and it has been suggested
that AnxA1 acts as a downstream modulator of their effects during
the resolution phase of inflammation, by enhancing neutrophil
apoptosis and efferocytosis (Vago et al., 2012; Dalli et al., 2013).
We therefore examined the effects of isopimpinellin, disodium
cromoglycate and nedocromil on neutrophil apoptosis in the
presence of dexamethasone. However, we did not detect increased
apoptosis in neutrophils exposed to dexamethasone in combination
with any of our compounds (Fig. 5D-F). Although these
experiments were not powered to detect a small effect, we have
excluded a difference of comparable magnitude to the in vivo data.
Cromones in clinical use might act indirectly to induce
neutrophil apoptosis in vivo
Our data suggest that isopimpinellin and the related clinical
cromones do not have a direct effect on neutrophil survival. We
suspected that this might be explained by the lack of a required
stimulus in our in vitro culture system because we had already
observed an increase in neutrophil apoptosis during inflammation
resolution in zebrafish larvae exposed to isopimpinellin (Fig. 3). To
similarly investigate the effects of disodium cromoglycate and
nedocromil in vivo, we performed inflammation resolution assays
and TSA/TUNEL staining in mpx:GFP larvae. Because these
cromones are inactive when given by immersion (data not shown)
(Yazid et al., 2010), we administered them at 6 hpi by vascular
injection into the Duct of Cuvier, a technique that has been used
previously for bacterial infection (Benard et al., 2012). At 12 hpi,
neutrophil numbers at the wound were reduced following injection
with either nedocromil or disodium cromoglycate, in comparison to
the vehicle control (Fig. 6A). We also found a significant increase
in the percentage of apoptosis of neutrophils at the wound in
nedocromil-injected larvae (Fig. 6B-D). The lack of effect in
isolated human neutrophils in vitro might be explained by an
indirect effect of the compound acting on neutrophils via another
cell type, such as macrophages. To test this, we used a combined
genetic/pharmacological macrophage ablation system, in which
transgenic expression of bacterial nitroreductase is driven by the
mpeg promoter and larvae are exposed to metronidazole treatment
(Prajsnar et al., 2012). When macrophages were partially ablated in
this manner, the effect of isopimpinellin was less significant,
indicating a partial dependence on macrophages for the
isopimpinellin response (Fig. 6E). Taken together, these data
suggest that isopimpinellin and the clinically available cromones
share both structural and functional similarity, acting to accelerate
inflammation resolution in vivo by indirect induction of neutrophil
apoptosis.
DISCUSSION
Neutrophil-dominated inflammatory diseases remain a large,
worldwide problem and there is a major unmet need for more
Fig. 3. Isopimpinellin accelerates inflammation resolution in vivo by
inducing neutrophil apoptosis. (A) Inflammation resolution assay in mpx:
GFP larvae treated with varying doses of isopimpinellin at 6 hpi. Isopimpinellin
significantly reduces neutrophil numbers at the wound at 12 hpi in a dose-
dependent manner (one-way ANOVA with Dunnett’s multiple-comparison
post-test; **P<0.01, ***P<0.001; n=18, performed as three independent
experiments). Dotted line at y=18.5 indicates mean neutrophil number at
wound in DMSO control larvae. (B) Total neutrophil number measured inmpx:
GFP larvae treated with DMSO or 25 μM isopimpinellin for 24 h. Isopimpinellin
did not affect total neutrophil number (unpaired t-test; P=0.8696; n=18,
performed as three independent experiments). (C) Reverse-migration assay in
mpx/Kaede larvae treated with DMSO or 25 μM isopimpinellin from 4 hpi.
Neutrophils at the site of injury were photoconverted at 6 hpi and the numbers
of photoconverted cells that moved away from the wound were quantified over
5 h. Neutrophils migrated away from the wound at a slower rate in
isopimpinellin-treated larvae compared to DMSO control larvae.
(D) Representative image of isopimpinellin-treated mpx/Kaede larvae at 8 hpi
(scale bar: 70 μm). Solid white line in the left panel indicates the outline of the
tail-fin, and the boxed area is magnified in the right-hand panel. White arrows in
magnified view indicate neutrophils that appear apoptotic. (E,F) FRET assay in
Tg(mpx:FRET)sh237 larvae treated with DMSO or 25 μM isopimpinellin from
4 hpi and imaged from 6 hpi. Cleavage of the caspase-3 target site results in
separation of the fluorophores and loss of the FRET signal (red, F). Acceptor
(neutrophil) fluorescence (green, F) persists for a further 10-20 min before cell
death and loss of fluorophore integrity. Time is shown as hours:minutes. Scale
bar: 50 μm. Number of observable apoptotic events was increased in
isopimpinellin larvae (unpaired t-test; ***P<0.001; n=18, performed as three
independent experiments). (G) TUNEL assay in mpx:GFP larvae treated with
DMSO or 25 μM isopimpinellin from 6 hpi and fixed at 12 hpi. Numbers of TSA-
positive neutrophils and TSA/TUNEL double-positive apoptotic neutrophils at
the site of injury were measured to calculate percentage neutrophil apoptosis,
which was increased in isopimpinellin-treated larvae (unpaired t-test;
***P<0.001; n=115, performed as two independent experiments). (H) Larvae
were treated with DMSO, 100 μM Z-VAD-FMK (zVAD), 25 μM isopimpinellin
(Iso) or in combination (Iso+zVAD) from 4 hpi and imaged from 6 hpi. Number
of observable apoptotic events was increased with isopimpinellin alone but the
effect was lost with the addition of Z-VAD-FMK (one-way ANOVA with
Bonferroni’s multiple-comparison post-test to compare selected columns;
*P<0.05; ns, non-significant; n=14, performed as three independent
experiments). (I) Larvae were treated with DMSO, 20 μM roscovitine or 50 μM
pyocyanin from 4 hpi and imaged from 6 hpi. Number of observable apoptotic
events was increased with pyocyanin (one-way ANOVA with Bonferroni’s
multiple-comparison post-test to compare selected columns; *P<0.05; n=18,
performed as three independent experiments).
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effective treatments. Drug discovery strategies focus on targeting
the mechanisms that regulate neutrophil recruitment and clearance
during inflammation resolution, and recent efforts to identify new
anti-inflammatory therapeutics have made use of the zebrafish
model (d’Alencon et al., 2010; Robertson et al., 2014). Many
features of the innate immune system are highly conserved between
zebrafish and mammalian species (Trede et al., 2004). In our tail-fin
injury assay, the cellular components and kinetics of the acute
Fig. 4. Isopimpinellin and disodium cromoglycate do not have antioxidant activity. (A) Isopimpinellin is a structural isomer of khellin, from which a series
of functional benzopyrone analogues were designed, including disodium cromoglycate and nedocromil. (B,C) FRAP assay, performed at 37°C for 5 min.
Graphs show the rate of increase in absorbance at 593 nm, corrected for reagent blank readings, at (B) 100 μM and (C) 400 μM of each compound, as indicated.
(D) The in vivo activity of the compounds tested (expressed as the percentage decrease in the mean neutrophil numbers at the wound at 12 hpi), in comparison to
the vehicle control (refers to data from Figs 3A, 6A and Fig. S3), plotted against the chemical reducing ability value (refers to data from Table S1) (linear regression
analysis;R
2
=0.8960; P=0.535). (E) In vivo antioxidation assay. Larvae were pretreated with DMSO, isopimpinellin or DPI for 2 h and pentafluorobenzenesulfonyl
fluorescein for 1 h prior to tail-fin injury. Imaging commenced 5 min post-injury (mpi) and mean fluorescence intensity at the injury site was measured at 5
and 20 mpi. Mean fluorescent intensity at 20 mpi is expressed as a percentage of the mean fluorescent intensity at 5 mpi. This was significantly reduced by
DPI but isopimpinellin had no effect (one-way ANOVA with Dunnett’s multiple-comparison post-test; ****P<0.0001; ns, non-significant; n>15, performed as two
independent experiments). Illustrative images are shown in F. Scale bar: 50 μm.
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inflammatory response are comparable to those in mammalian
systems, making this a useful model to study inflammation and
dissect the mechanisms that might become disrupted to cause
inflammatory disease (Renshaw et al., 2006).
In this study, we investigated the mechanism of action of a group
of structurally similar compounds that we identified in our recent
in vivo screen for accelerators of inflammation resolution
(Robertson et al., 2014). We describe the anti-inflammatory and
pro-resolution activity of isopimpinellin, which, in our assays, was
the most active compound within this subset. Based on our previous
hierarchical cluster analysis, we were able to accurately predict that
the mechanism by which isopimpinellin inhibits neutrophil
recruitment is dependent on PI3K signalling. This explains, at
least in part, the differences in chemotactic behaviour that we
observed during the recruitment phase of the inflammatory
response. Over the course of our time-lapses, neutrophils from
isopimpinellin-treated larvae did not migrate preferentially towards
the wound and did not travel as quickly or as far as neutrophils from
control larvae. Directed neutrophil migration relies on polarisation
of the cell, which is dependent on localised PI3K signalling at the
leading edge. Using the transgenic lyz/PHAkt reporter line, we
showed that isopimpinellin treatment resulted in a loss of the
plasma-membrane localisation of PHAkt-EGFP and a rounded-tail
neutrophil phenotype, similar to the effect of the known PI3K
inhibitor LY294002 that we and others have previously observed
(Yoo et al., 2010; Wang et al., 2014; Burgon et al., 2014).
Interestingly, LY294002 is structurally similar to the compounds we
have investigated in this study, and was originally developed as an
analogue of quercetin, a benzopyrone that inhibits PI3K by blocking
the ATP-binding site (Vlahos et al., 1994). Wemeasured a reduction
in the polarity index of neutrophils from both isopimpinellin-treated
larvae and those treated with another compound from our
structurally similar subset, xanthone. Our data suggest that these
compounds act either directly on or upstream of PI3K, resulting in
reduced phosphorylation and translocation of the PH domain of Akt
to the plasma membrane, and disruption of directional migration
towards the wound.
Alongside its inhibitory effect on neutrophil recruitment, we
found that isopimpinellin also accelerated inflammation resolution
in vivo. Our data suggest that this occurs as a result of increased
neutrophil apoptosis, rather than reverse migration, which is perhaps
to be expected given that PI3K is also thought to be important for
neutrophil migration away from a wound (Yoo et al., 2010).
Neutrophil apoptosis followed by phagocytic uptake by
macrophages is the best-described process by which neutrophils
are removed during inflammation resolution (Savill et al., 1989).
Current approaches to reliably detect neutrophil apoptosis as it
occurs in vivo are limited. Although it is possible to label apoptotic
neutrophils in zebrafish larvae post-fixation, this provides only a
snapshot of the entire resolution phase. Here, we have developed a
new in vivo FRET reporter line for caspase-3 activity that enables us
to visualise neutrophil apoptosis in real time. When caspase-3 is
activated in neutrophils, the FRET signal is lost, prior to and
independently of the loss of GFP we have seen previously when
neutrophils undergo apoptosis in our mpx:GFP zebrafish (Loynes
et al., 2010). Our data indicate that the pro-apoptotic effect of
isopimpinellin is caspase-3-dependent and, although neutrophil
apoptosis occurs rarely in zebrafish larvae during the inflammatory
response, it is possible to pharmacologically manipulate this process
to promote resolution. Our new reporter line could provide a useful
tool for studying the mechanisms regulating neutrophil apoptosis
in vivo and for the identification of compounds that induce
neutrophil apoptosis.
Intriguingly, the clinically available mast cell stabilisers
disodium cromoglycate and nedocromil are benzopyrone
derivatives with incompletely defined anti-inflammatory activity.
Given their structural similarity to isopimpinellin, we hypothesised
that neutrophil apoptosis might be a previously unidentified
Fig. 5. Isopimpinellin and related clinical cromones have no effect on human neutrophil apoptosis in vitro. (A-F) Human neutrophils were isolated from
whole blood and incubated for 8 h with (+) or without (−) 0.01 μg/ml GM-CSF or 1 μM dexamethasone (Dex) as indicated, and 10 μM (A,D) isopimpinellin,
(B,E) disodium cromoglycate or (C,F) nedocromil. In each case, two cytospins (technical replicates) were acquired per condition and the percentage of neutrophil
apoptosis was calculated based on nuclear morphology. Experiments in A,B and D-F were performed at the same time using the same controls. Isopimpinellin,
disodium cromoglycate and nedocromil did not induce neutrophil apoptosis compared to their vehicle controls, or inhibit neutrophil survival induced by either
GM-CSF or dexamethasone [one-way ANOVA with Bonferroni’s multiple comparison post-test to compare selected columns; P>0.05 for all comparisons
(ns, non-significant); n=2, performed as independent experiments from two different donors performed on different days].
628
RESEARCH ARTICLE Disease Models & Mechanisms (2016) 9, 621-632 doi:10.1242/dmm.024935
D
is
e
a
s
e
M
o
d
e
ls
&
M
e
c
h
a
n
is
m
s
mechanism of action for these compounds. In our human neutrophil
assays, we did not detect any change in the rate of apoptosis in the
presence of isopimpinellin or either of the clinical cromones. This
was unexpected given that similar compounds have been reported to
induce neutrophil apoptosis in vitro and to override survival factors
including GM-CSF and dexamethasone (Lucas et al., 2013). It is
possible that subtle differences in the chemical structures of the
benzopyrone derivatives have profound effects on their biological
activity, for example by affecting target binding, metabolism or their
ability to permeate the cell membrane. Because we were unable to
detect an increase in neutrophil apoptosis with nedocromil or
disodium cromoglycate in vitro, we cannot speculate on the
involvement of AnxA1, the release of which can be induced by
these compounds (Yazid et al., 2010). Given our evidence that
nedocromil and isopimpinellin can induce neutrophil apoptosis and
promote inflammation resolution in vivo, we suspect that another
stimulus or cell type might be important for mediating their activity.
Our macrophage ablation experiments suggest that the effect of
isopimpinellin might be at least partially dependent on
macrophages. Further investigation is required to dissect this
mechanism and establish the effect of nedocromil in the absence
of these cells. Disodium cromoglycate also accelerated
inflammation resolution in our system, although we were unable
to confirm that this was due to an increase in neutrophil apoptosis.
Nedocromil was developed as a more potent and stable alternative to
disodium cromoglycate (Edwards and Stevens, 1993), which we
suspect could explain the difference in activity that we observed
between these two compounds.
The mechanism of action of isopimpinellin and related
chromones and coumarins remains to be determined. Our FRAP
studies indicate that the active compounds we tested do not act as
antioxidants through single-electron transfer. Although these
results alone do not rule out the possibility that they might act as
oxygen-radical scavengers, when taken together with our in vivo
data, an antioxidant mechanism seems unlikely.We did not observe
a reduction in the H2O2 gradient at the site of injury in
isopimpinellin-treated larvae, in comparison to those treated with
the NADPH oxidase inhibitor, DPI. However, the ROS sensor used
in these experiments is not specific to H2O2 and we cannot rule out
the possibility that isopimpinellin might reduce the levels of other
ROS. A recent report describes antagonism of the AnxA1 receptor,
formyl peptide receptor 1 (FPR1), by a series of benzopyrone
Fig. 6. Clinical cromones promote neutrophil apoptosis to
drive inflammation resolution in vivo. (A) Inflammation-
resolution assay in mpx:GFP larvae injected with 0.4 pg/μl
nedocromil or 0.5 pg/μl disodium cromoglycate at 6 hpi. Both
compounds significantly reduce neutrophil numbers at the
wound at 12 hpi compared to the water control (one-way
ANOVA with Dunnett’s multiple-comparison post-test; *P<0.5;
n>36, performed as four independent experiments). (B-D)
TUNEL assay in mpx:GFP larvae injected with water, 0.4 pg/μl
nedocromil or 0.5 pg/μl disodium cromoglycate from 6 hpi and
fixed at 12 hpi. Numbers of TSA-positive neutrophils and TSA/
TUNEL double-positive apoptotic neutrophils at the site of
injury were measured to calculate percentage neutrophil
apoptosis, which was increased in nedocromil-treated larvae
(one-way ANOVA with Dunnett’s multiple-comparison post-
test; *P<0.05; n>54, performed as three independent
experiments). (C,D) Illustrative images of water-injected (C)
and nedocromil-injected (D) larvae following TSA/TUNEL
staining (scale bars: 40 μm). Broken lines indicate the outline of
the tail-fin. White arrows in magnified view of boxed area in Diii
(Div) indicate apoptotic neutrophils, identified by morphology
and double TSA/TUNEL labelling. (E) Inflammation-resolution
assay in the absence of macrophages. Metronidazole ablation
of macrophages impairs the effect of isopimpinellin (one-way
ANOVA with Bonferroni’s multiple-comparison post-test to
compare selected columns; *P<0.05; ns, non-significant; n>20;
performed as three independent experiments).
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analogues (Schepetkin et al., 2014). The precise functions of
AnxA1 and FPR1 signalling during inflammation resolution have
not yet been well-established and we suspect that the effects of
FPR1 activation over the course of the inflammatory response
might be temporally dependent. An alternative mechanism of
action for the cromones has also been proposed. Two research
groups have demonstrated that disodium cromoglycate and
nedocromil might activate the G-protein-coupled receptor GPR35
to induce calcium mobilisation, inositol phosphate accumulation
and β-arrestin-2 recruitment in transfected cells (Jenkins et al.,
2010; Yang et al., 2010).
In summary, we have identified a series of lead compounds with
the potential both to limit the further recruitment of neutrophils to
areas of inflammation and also to promote the clearance of
persistent neutrophils that are already in situ. This combined anti-
inflammatory and pro-resolution activity might make these
compounds particularly valuable for the treatment of chronic
inflammatory diseases. Further investigation is necessary to
determine the precise mechanism of action of isopimpinellin and
other benzopyrone analogues in vivo.
MATERIALS AND METHODS
Reagents
Isopimpinellin (MicroSource Discovery Systems Inc., Gaylordsville, CT,
USA) was used at 25 μM unless indicated otherwise. Xanthone was used at
25 μM unless stated otherwise, LY294002 at 50 μM, pyocyanin at 50 μM
and disodium cromoglycate at 0.5 pg/μl (all obtained from Sigma-Aldrich,
Poole, UK). Roscovitine was used at 20 μM (New England Biolabs, Hitchin,
UK) and Z-VAD-FMK at 100 μM (Calbiochem, Manchester, UK).
Nedocromil was used at 0.4 pg/μl and was a kind gift from Professor Rod
Flower (William Harvey Research Institute, London, UK). The related
benzopyrones anthraquinone, 4-chromanone, 1,2,3,4-tetrahydranaphthalene
and xanthene were also obtained from Sigma-Aldrich, whereas anthrone and
dihydrocoumarin were acquired from Alfa Aesar (Heysham, UK) and
α-tetralone from L. Light & Co. Ltd (Colnbrook, UK). GM-CSF (from
PeproTech, London, UK) was used at 0.01 μg/ml. Zebrafish were treated
with compounds by immersion, with the exceptions of disodium
cromoglycate and nedocromil, which were administered by vascular
injection into the Duct of Cuvier, alongside fluorescein as a marker for
successful injection. DMSO (Sigma-Aldrich) or water were used as vehicle
controls, as indicated.
Analogue compound synthesis
Compounds were synthesised according to literature procedures as follows:
MMM101 using a slightly modified procedure (Pirkle and Finn, 1983);
MMM103 (Niwa et al., 2008); MMM115 (Fougerousse et al., 2000; Hirao
et al., 1984); MMM116P using an adapted method (Mouysset et al., 1988);
MMM117 using a modified procedure (Bird et al., 1983).
Transgenic zebrafish generation and maintenance
Zebrafish were raised and maintained according to standard protocols
(Nusslein-Volhard and Dahm, 2002), in UK Home Office-approved aquaria
at the Bateson Centre, University of Sheffield. The neutrophil-specific
zebrafish line Tg(mpx:GFP)i114 (Renshaw et al., 2006), referred to as mpx:
GFP, was used for all experiments unless stated otherwise. All procedures
were performed on larvae at 3 days post-fertilisation (dpf). Inflammation was
initiated by tail-fin transection and neutrophil numbers at the wound were
recorded following our standard protocols (Renshaw et al., 2006; Robertson
et al., 2014). The Tg(mpx:FRET)sh237 line, referred to as mpx:FRET, was
generated by BAC recombineering as previously described (Renshaw et al.,
2006), using a caspase-3-specific FRET reporter (Tyas et al., 2000).
In vivo neutrophil recruitment assays
For neutrophil recruitment assays, mpx:GFP larvae were treated with
compounds at the dose indicated immediately after wounding and numbers
of neutrophils at the site of injurywere counted at 6 h post-injury (hpi). To track
neutrophil migration during the recruitment phase of inflammation, larvae
were pretreated for 2 h prior to tail-fin transection, followed by mounting in
0.8% low-melting-point agarose containing the appropriate drug at 1 hpi. A 2-
h time-lapse series was captured and neutrophils were manually tracked using
Volocity™ imaging software (PerkinElmer Life and Analytical Sciences,
Cambridge, UK) for analysis of speed, meandering index, displacement and
bearing, as previously described (Elks et al., 2011; Robertson et al., 2014).
PI3K assays were performed using Tg(lyz.PHAkt:GFP)i277 larvae, which
were pre-incubated with test compounds for 2 h, followed by wounding,
imaging and polarity analysis as described (Wang et al., 2014).
In vivo inflammation-resolution assays
For inflammation-resolution assays, mpx:GFP larvae were treated at 6 hpi
once inflammation was already established, and neutrophil numbers at the
wound were counted at 12 hpi. Total neutrophil numbers were analysed in
uninjured larvae following compound treatment for 24 h, as previously
described (Robertson et al., 2014). Images were converted to 8-bit, binary
TIFs using ImageJ (NIH), and the ‘Measure’ function was used to count the
number of neutrophils in an automated manner. Reverse migration assays
were performed using Tg(mpx:Gal4);Tg(UAS:Kaede)i222 larvae following
established methods (Elks et al., 2011; Holmes et al., 2012). Neutrophil
apoptosis was measured in paraformaldehyde-fixed larvae following
Tyramide Signal Amplification staining (TSA™-Plus, PerkinElmer) to
label neutrophil myeloperoxidase and using an ApopTag® Red In Situ
Apoptosis Detection Kit (TUNEL) (Millipore Corporation, Herts, UK) to
label apoptotic cells, as previously described (Elks et al., 2011). The
percentage of neutrophil apoptosiswasmeasured usingVolocity™ software.
FRET assay
Tail-fin transection was performed on Tg(mpx:FRET)sh237 larvae at 3 dpf
followed by treatment with compounds at 4 hpi. Larvae were mounted and
FRET imaging was performed from 6 hpi. Embryos were imaged for 6 h on
a TE-2000U microscope (Nikon, Japan) with an Orca-AG Camera
(Hamamatsu, Japan) using Volocity™ imaging software. Donor
fluorescence was imaged with a D436/20× CFP excitation filter and a
D480/40m CFP emission filter. Acceptor fluorescence was imaged with a
HQ500/20× YFP excitation filter and an HQ535/30m emission filter. FRET
images were taken with the CFP excitation and the YFP emission filters,
using a 455DCLP dichroic mirror (Chroma, Germany). Spectral bleed-
through constants were calculated using fixed HEK293T cells transfected
with either p1CFP or p1YFP and mounted in VECTASHIELD mounting
media (Vector Laboratories, Peterborough, UK). Volocity™ was used to
calculate NFRET (normalised FRET value) (Xia and Liu, 2001).
In vivo antioxidation assays
At 3 dpf, zebrafish larvae (nacre) were treated with DMSO, isopimpinellin
or DPI (100 μM, Sigma-Aldrich) for 2 h prior to injury. Incubation in the
appropriate compound was continued during injury and subsequent
imaging. During the pretreatment period, the larvae were also incubated
in pentafluorobenzenesulfonyl fluorescein (10 μM, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) in the dark for 1 h. The dye was
removed prior to mounting. After 2 h pretreatment, larvae were mounted in
agarose containing the appropriate compound. A window was cut in the
agarose to allow prompt imaging of the larval tail after injury. Tail-fin
transection was performed and imaging commenced at 5 min post-injury
(mpi). Mean fluorescent intensity at the injury site was measured at 5 mpi
and 20 mpi using ImageJ. Mean fluorescent intensity at 20 mpi was
expressed as a percentage of the mean fluorescent intensity at 5 mpi.
Ferric reducing ability of plasma (FRAP) assays
The method of Benzie and Strain (1996) was followed with slight
modifications. 300 mM acetate buffer (pH 3.6) was prepared from 3.1 g
sodium acetate trihydrate (Alfa Aesar, Heysham, UK) and 16 ml glacial
acetic acid (VWR International, Lutterworth, UK) made up to 1 litre with
distilled water. Other reagents used were 10 mM 2,4,6-Tris(2-pyridyl)-s-
triazine (TPTZ) (Sigma-Aldrich) in 40 mM hydrochloric acid (VWR
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International), and aqueous 20 mM iron (III) chloride hexahydrate (BDH
Laboratory Supplies, Poole, UK). FRAP reagent was prepared freshly as
required, by mixing 10 ml acetate buffer, 1 ml TPTZ solution and 1 ml iron
(III) chloride hexahydrate solution. Aqueous standard solutions of iron (II)
at concentrations of 100, 200, 400, 600, 800 and 1000 µM were prepared
using iron (II) sulfate heptahydrate (Sigma-Aldrich), and their absorbances
at 593 nm at 37°C were used for calibration of the assay, using a line of best
fit as determined by linear regression analysis. Solid L-(+)-ascorbic acid,
vanillic acid and disodium cromoglycate (all obtained from Sigma-Aldrich)
were tested as aqueous solutions, whereas isopimpinellin was used as an
ethanolic solution. All compounds were tested at both 100 µM and 400 µM.
All UV-visible spectrometry was carried out using a Cary 50 Probe UV-
Visible Spectrophotometer (Varian) pre-warmed to 37°C using awater bath,
and in a quartz cuvette of 1-cm path length. Absorbance values at 593 nm
were plotted using the Cary WinUV Kinetics application (Varian, version
3.00). 3 ml freshly prepared FRAP reagent in a quartz cuvette was warmed
to 37°C, and a blank reading was taken at 593 nm. A 100 µl sample of
compound solution was then added, and absorbance readings were taken
after 0.1 s and then at 15-s intervals for a total of 5 min (after which the
absorbance values for most samples had stabilised). These were then
corrected relative to the blank reading. The absorbance value of the sample
at 5 min was then used for all future calculations. For each sample, the
effective iron (II) concentration in solution corresponding to that absorbance
value was determined, using the calibration graph (described above). This
value was then compared to the corresponding iron (II) standard value for
the same concentration of reagent (i.e. 100 or 400 µM), and was expressed
as a ratio, for each of the two concentrations tested. These ratios were then
used to determine the mean ratio for each compound, referred to as the
chemical reducing ability value.
Macrophage ablation experiments
Zebrafish larvae from Tg(mpeg:gal4)SH256; Tg(UAS:nfsB.mCherry)C264;
Tg(mpx:GFP)i114 zebrafish were raised to 2 dpf and then incubated with or
without metronidazole (5 mM) for approximately 16 h. At 3 dpf, tail-fin
transection was performed and larvae were returned to metronidazole
(1.25 mM) or vehicle only for the remainder of the experiment. At 6 hpi,
larvae with a good inflammatory response were treated with isopimpinellin
or DMSO. At 12 hpi, the number of neutrophils at the site of injury was
counted. All groups were kept in the dark throughout the experiment.
Human neutrophil apoptosis assay
Peripheral blood neutrophils were purified using the Percoll method of
separation, as described previously (Haslett et al., 1985), in accordance with
the South Sheffield Research Ethics Committee (reference number:
STH13927). Rates of neutrophil apoptosis based on morphology were
counted on cytospins stained with Quick-Diff (Gentaur, Brussels, Belgium).
Statistical analysis
Data were analysed (Prism 6.0; GraphPad Software, CA, USA) using
unpaired, two-tailed t-tests for comparisons between two groups and one-
way ANOVA (with appropriate post-test adjustment) for other data. In all
cases, mean±s.e.m. are shown and procedures were performed and analysed
blind to experimental conditions.
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